Aesthetic Medical International Holdings Group Ltd.

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Aesthetic Medical International 4Q and Fiscal Year 2020 Unaudited Financial Results Conference Call. During today's presentation, all parties will be in a listen-only mode. This conference has been recorded today, Tuesday, April 20th, 2021. Joining us today from Aesthetic Medical International are the company's chairman and CEO, Dr. Peng Wu Zhou, and company's IRD, Mr. Chun-Wei Wang, and company's chief financial officer, Mr. Guanghua Wu. Before we get started, I would like to remind you that some of the information discussed will include forward-looking statements. regarding future events and our future financial performance. These include statements about our future expectations, financial projections, and our plans and prospects. Actual results may differ materially from those set forth in such statements. For discussion of these risks and uncertainties, you should review the company's filings with the SEC, which includes today's press release. You should not rely on our forward-looking statements as prediction of future events. Our forward-looking statements that we make on this call are based on assumptions and beliefs as of today, and we undertake no obligation to update them except as required by applicable law. Our discussion today will include non-IFRS financial measures, including a visa requirement adjusted profit, and adjusted EBITA. You should not consider EBITA or adjusted EBITA and adjusted profit as a substitute for or superior to net income prepared in accordance with IFRS. Furthermore, because non-IFRS measures are not determined in accordance with IFRS, They are susceptible to varying calculations and may not be comparable to other similarly titled measures presented by other companies. You are encouraged to review the company's financial information in its entirety and not rely on single financial measures. At this time, I would like to turn the call over to Mr. Feng-Wei Zhou, Chairman and CEO of Aesthetic Medical International. His opening remarks will be delivered in English by IRD Mr. Chung Yik Wong. Mr. Zhou, please go ahead.

Thank you, host. Thank you all for attending EMEI International's 4th quarter of 2020 and the entire year's financial performance. First of all, I would like to summarize the company's response to the COVID-19 pandemic in 2020, and the performance of the company in 2020. Then, our investor relations director, Mr. Jiang, will give a more detailed interpretation and explanation of our financial statements, the operating situation of the company, Thank you, Officer, and everyone for joining Athletic Electrical International's fourth quarter at fiscal year 2020 and on the earning call today.

I will begin my remarks by providing an overview of the company's response to the COVID-19 outbreak during the fiscal year 2020, followed by a summary of the company's fiscal year 2020 performance. Then, Mr. Janik Wong, our RRD, will review our financial results and operation performance in more detail, and he will elaborate a few other items related to our outlooks and the approaches that we are taking to implement our core initiatives in the next fiscal year.